The Novo Nordisk Prize
The Novo Nordisk Prize
Benefitting medical science
The Novo Nordisk Prize recognizes an active scientist who has provided outstanding international contributions to advance medical science for the benefit of people’s lives.
The Prize is intended to award and further support biomedical research in Europe.
The Prize is of DKK 5 million (appr. EUR 672,000) and consists of a DKK 4,5 million (appr. EUR 605,000) research grant and a personal award of DKK 0,5 million (appr. EUR 67,000).
The Foundation will grant an additional DKK 0,5 million for hosting an international symposium within the recipient’s field(s) of research.
The nomination call will be open from April 15th to June 1st, 2021.
The Foundation welcomes nominations by individual researchers and by research institutions including academic institutions and research funding agencies.
The nomination and review processes are confidential.
Eligibility – Nominees:
- must demonstrate scientific excellence that has led to a major discovery or breakthrough in understanding of human health and disease, prevention, diagnosis and/or treatment of the disease.
- must have a current position and an active research program at a public or non-profit research institution in a European country.
- must serve as inspirational leaders and role models for young scientists.
- may have any nationalities.
- Self-nominations are not accepted
- Nominators cannot be family members
- The prize may not be awarded to members of the Novo Nordisk Foundation Board or committee members or to Board members, directors or employees of the Novo Group.
The Foundation’s collaborating partners and the recipient’s guests are invited to the prize ceremony in April or May, where the prize recipient introduces his or her research for 15–20 minutes. The ceremony takes place in Copenhagen, Denmark.
In addition, the recipient gives a lecture at his/her workplace.
History of the Prize
The prize, originally DKK 50,000, was first awarded on 16 February 1963. Since then, the amount awarded gradually increased. The prize was called the Novo Prize from 1963 until 1989, when it was renamed the Novo Nordisk Prize. Until 2020 the Prize was given for a Danish contribution. In 2020, it has been decided to change the geographical scope of the prize and from 2021 the prize will be awarded for a European contribution.
The 2020 Novo Nordisk Prize
The 2020 Novo Nordisk Prize was awarded to Professor Merete Nordentoft and Professor Preben Bo Mortensen for their pioneering clinical and epidemiological research contributions to Danish medical science. Read more here.